Literature DB >> 22576640

Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin.

Daniele Sanna1, Valeria Ugone, Giovanni Micera, Eugenio Garribba.   

Abstract

The behaviour of the systems formed by VO(2+), 2-hydroxypyridine-N-oxide (Hhpo) and 2-mercaptopyridine-N-oxide (Hmpo) was studied both in solution and in the solid state through the combined application of spectroscopic (EPR and UV-Vis spectroscopy) and DFT methods. The geometry of solid bis-chelated complexes [VOL(2)], with L = hpo and mpo, is square pyramidal, but it can change to cis-[VOL(2)S], where S is a solvent molecule, when these are dissolved in a coordinating solvent. The equilibrium between the square pyramidal and cis-octahedral forms is strongly affected by solvent and temperature. At room temperature, the predominant species is [VOL(2)], which gives a pink colour to the solutions; at lower temperatures, the equilibrium is shifted--partially or completely--toward the formation of cis-[VOL(2)S], which is green. In an acidic environment and in the presence of an excess of ligand, [VOL(2)] can transform into the tris-chelated complex [VL(3)](+), in which vanadium loses the oxido ligand and adopts a hexa-coordinated geometry intermediate between octahedral and trigonal prismatic. 1-Methylimidazole (1-MeIm), which represents a model for His-N coordination, forms mixed complexes with stoichiometry cis-[VOL(2)(1-MeIm)], occupying an equatorial position. In the ternary systems VO(2+)-Hhpo-hTf and VO(2+)-Hmpo-hTf at room temperature and pH 7.4, besides (VO)hTf and (VO)(2)hTf, the mixed species cis-VO(hpo)(2)(hTf) and VO(mpo)(hTf) are observed, with the equatorial binding of an accessible histidine residue. Finally, the contribution of the N-oxide group to (51)V A(z) and A(iso) hyperfine coupling constants, which can be important in the characterisation of similar species, is discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22576640     DOI: 10.1039/c2dt12503j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  4 in total

1.  Ameliorative effect of an oxovanadium (IV) complex against oxidative stress and nephrotoxicity induced by cisplatin.

Authors:  Abhishek Basu; Arin Bhattacharjee; Subhadip Hajra; Amalesh Samanta; Sudin Bhattacharya
Journal:  Redox Rep       Date:  2016-11-29       Impact factor: 4.412

2.  Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme.

Authors:  Giarita Ferraro; Maddalena Paolillo; Giuseppe Sciortino; Eugenio Garribba; Antonello Merlino
Journal:  Inorg Chem       Date:  2022-10-07       Impact factor: 5.436

3.  Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients.

Authors:  Gail R Willsky; Katherine Halvorsen; Michael E Godzala; Lai-Har Chi; Mathew J Most; Peter Kaszynski; Debbie C Crans; Allison B Goldfine; Paul J Kostyniak
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

4.  ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins.

Authors:  Valeria Ugone; Daniele Sanna; Giuseppe Sciortino; Debbie C Crans; Eugenio Garribba
Journal:  Inorg Chem       Date:  2020-06-25       Impact factor: 5.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.